22q11.2微缺失综合征中帕金森病的典型特征与诊断挑战
这项国际观察性研究描述了45例22q11.2缺失综合征合并帕金森病患者的临床与神经影像特征,随访平均7.5±4.1年。患者以男性为主,运动症状起病年龄较轻,对左旋多巴初始反应良好,但既往抗精神病药物治疗者诊断延迟。
要点
- 22q11.2缺失综合征相关帕金森病以男性为主(32例,71.1%),运动症状起病年龄较轻(平均39.5±8.5岁)。
- 有抗精神病药物治疗史者帕金森病诊断延迟(中位5年 vs 1年,p=0.001)。
- 93.3%患者对左旋多巴初始反应良好,纹状体多巴胺转运体结合减少。
核心结论
- 22q11.2缺失综合征相关帕金森病的主要临床特征和对标准治疗的反应与特发性帕金森病相当,但平均起病年龄更早。
- 治疗既存精神疾病可能延迟22q11.2缺失综合征患者的帕金森病诊断。
- 保持怀疑指数和对复杂共病的警惕可能有助于识别应优先进行基因检测的患者。
研究设计与样本
- 国际观察性研究,纳入45例22q11.2缺失综合征合并帕金森病患者,平均随访7.5±4.1年。
主要发现
- 男性32例(71.1%),平均运动症状起病年龄39.5±8.5岁,71.4%为早发型帕金森病(<45岁)。
- 93.3%患者对左旋多巴初始反应良好,分子影像显示纹状体多巴胺转运体结合减少。
- 有抗精神病药物治疗史者帕金森病诊断延迟,中位5年 vs 无抗精神病药物史者中位1年(p=0.001)。
- 既存精神障碍占24.5%,情绪或焦虑障碍占31.1%,早期肌张力障碍占19.4%,癫痫史占33.3%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To delineate the natural history, diagnosis, and treatment response of Parkinson disease (PD) in individuals with 22q11.2 deletion syndrome (22q11.2DS), and to determine if these patients differ from those with idiopathic PD. METHODS: In this international observational study, we characterized the clinical and neuroimaging features of 45 individuals with 22q11.2DS and PD (mean follow-up 7.5 ± 4.1 years). RESULTS: 22q11.2DS PD had a typical male excess (32 male, 71.1%), presentation and progression of hallmark motor symptoms, reduced striatal dopamine transporter binding with molecular imaging, and initial positive response to levodopa (93.3%). Mean age at motor symptom onset was relatively young (39.5 ± 8.5 years); 71.4% of cases had early-onset PD (<45 years). Despite having a similar age at onset, the diagnosis of PD was delayed in patients with a history of antipsychotic treatment compared with antipsychotic-naive patients (median 5 vs 1 year, p = 0.001). Preexisting psychotic disorders (24.5%) and mood or anxiety disorders (31.1%) were common, as were early dystonia (19.4%) and a history of seizures (33.3%). CONCLUSIONS: Major clinical characteristics and response to standard treatments appear comparable in 22q11.2DS-associated PD to those in idiopathic PD, although the average age at onset is earlier. Importantly, treatment of preexisting psychotic illness may delay diagnosis of PD in 22q11.DS patients. An index of suspicion and vigilance for complex comorbidity may assist in identifying patients to prioritize for genetic testing.
引用
- Boot E, Butcher NJ, Udow S, et al. Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2. Neurology. 2018. PMID: 29752303. doi:10.1212/WNL.0000000000005660
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。